CEACAM5 and neoplasm: To assess whether the 10-DM model exhibits advance in the diagnosis, we benchmarked the 10-DM model’s prediction accuracy against that of the 3 existing clinical tumor biomarkers CA19-9, CA72-4, and CEA (collectively named 3-biomarker panel).